NCT04271813 2024-04-23Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)Shanghai Changzheng HospitalPhase 2 Completed30 enrolled
NCT02332499 2019-05-21ALTER0703Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2/3 Completed419 enrolled